MARIETTA, Ga., Sept. 18, 2014 /PRNewswire/ -- Eprida Technologies*, a member of the Georgia Institute of Technology ATDC (Advanced Technology Development Center**), is building a manufacturing and distribution facility in Georgia for its rapidly growing subsidiary, H2forLife LLC.
Eprida Technologies has signed export distribution and investment agreements with strategic partners from the U.S. and China to fund this expansion. The company has also signed an agreement with Design Group Facility Solutions***, global specialists in engineering liquid packaging and facilities construction.
The new manufacturing capacity will allow H2forLife to meet growing demand from distributors in China and the United States, as well as creating a number of quality local manufacturing jobs.
H2forLife is made with purified spring water from the Appalachian Mountains, enriched with molecular hydrogen and colloidal platinum. This combination has been shown in scientific research to be highly effective and safe in removing harmful free radicals.**** Visit www.H2forLife.com to learn about the beneficial effects of drinking this hydrogen enriched dietary supplement.
H2forLife is manufactured at 4374 Shallowford Industrial Parkway, Marietta, Georgia. It is currently sold online nationwide, directly from the manufacturing center and through retail distributors in Georgia, North Carolina, and Florida. The company also markets through local restaurants, such as Windy City Grill in Marietta, where customers can supplement their meals with this new Georgia based product.
*Eprida is a technology development firm offering consulting, equipment design and technology licensing.
** The Advanced Technology Development Center at Georgia Tech is one of the world's leading startup technology business incubators helping entrepreneurs launch successful companies. http://atdc.org
*** Design Group Facility Solutions is a division of the Barry-Wehmiller Companies, Inc. providing design and engineering services to global beverage companies. http://www.bwdesigngroup.com
****This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Submitted by Eprida Technologies, Danny Day, [email protected], 404-793-6999
SOURCE Eprida Technologies
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article